Cargando…
Extracellular Vesicles: A Novel Tool Facilitating Personalized Medicine and Pharmacogenomics in Oncology
Biomarkers that can guide cancer therapy based on patients’ individual cancer molecular signature can enable a more effective treatment with fewer adverse events. Data on actionable somatic mutations and germline genetic variants, studied by personalized medicine and pharmacogenomics, can be obtaine...
Autores principales: | Goričar, Katja, Dolžan, Vita, Lenassi, Metka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8120271/ https://www.ncbi.nlm.nih.gov/pubmed/33995103 http://dx.doi.org/10.3389/fphar.2021.671298 |
Ejemplares similares
-
Extracellular Vesicle Enriched miR-625-3p Is Associated with Survival of Malignant Mesothelioma Patients
por: Goričar, Katja, et al.
Publicado: (2021) -
Plasma Extracellular Vesicle Characteristics as Biomarkers of Resectability and Radicality of Surgical Resection in Pancreatic Cancer—A Prospective Cohort Study
por: Badovinac, David, et al.
Publicado: (2023) -
Urinary Extracellular Vesicles and Their miRNA Cargo in Patients with Fabry Nephropathy
por: Levstek, Tina, et al.
Publicado: (2021) -
Extracellular vesicle‐bound DNA in urine is indicative of kidney allograft injury
por: Sedej, Ivana, et al.
Publicado: (2022) -
Plasma Extracellular Vesicle Characteristics Correlate with Tumor Differentiation and Predict Overall Survival in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Surgery with Curative Intent
por: Badovinac, David, et al.
Publicado: (2021)